{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:24:45Z","timestamp":1792430685418,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015800","name":"Jilin Province Development and Reform Commission","doi-asserted-by":"publisher","award":["2019C050-4"],"award-info":[{"award-number":["2019C050-4"]}],"id":[{"id":"10.13039\/100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073784"],"award-info":[{"award-number":["82073784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajps.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T23:43:53Z","timestamp":1660779833000},"page":"630-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Yarong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesheng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajps.2022.07.004_bib0001","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jcmm.16119","article-title":"Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis","volume":"25","author":"Du","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.ajps.2022.07.004_bib0002","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1002\/jcp.30097","article-title":"Thymoquinone alleviates liver fibrosis via miR-30a-mediated epithelial-mesenchymal transition","volume":"236","author":"Geng","year":"2020","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.ajps.2022.07.004_bib0003","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.118.256156","article-title":"Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis","volume":"370","author":"Chen","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12951-020-00645-y","article-title":"Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy","volume":"18","author":"Ji","year":"2020","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.ajps.2022.07.004_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrgastro.2013.244","article-title":"Liver: hepatic stellate cells hold the key to liver fibrosis","volume":"11","author":"Ray","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.ajps.2022.07.004_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111598","article-title":"Mesenchymal stem cells influence activation of hepatic stellate cells, and constitute a promising therapy for liver fibrosis","volume":"9","author":"Lee","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ajps.2022.07.004_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver sirna against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"48","key":"10.1016\/j.ajps.2022.07.004_bib0008","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2020.03.011","article-title":"Hepatic fibrosis: a convergent response to liver injury that is reversible","volume":"73","author":"Wang","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajps.2022.07.004_bib0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/Smad genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"issue":"570","key":"10.1016\/j.ajps.2022.07.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav5183","article-title":"Specificity, versatility, and control of TGF-beta family signaling","volume":"12","author":"Derynck","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.ajps.2022.07.004_bib0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF -beta1 - a truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF -beta pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"10","key":"10.1016\/j.ajps.2022.07.004_bib0014","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF -beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the smad pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2022.07.004_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-beta\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.ajps.2022.07.004_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ajps.2022.07.004_bib0017","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","article-title":"Getting to the heart of the matter new insights into cardiac fibrosis","volume":"116","author":"Leask","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.ajps.2022.07.004_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10735-020-09859-8","article-title":"Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF -beta\/Smad signaling pathway","volume":"51","author":"Zhang","year":"2020","journal-title":"J Mol Histol"},{"issue":"14","key":"10.1016\/j.ajps.2022.07.004_bib0020","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1242\/dev.126.14.3253","article-title":"Regulation of midline development by antagonism of lefty and nodal signaling","volume":"126","author":"Bisgrove","year":"1999","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.ajps.2022.07.004_bib0021","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ajmg.1250","article-title":"Role of asymmetric signals in left-right patterning in the mouse","volume":"101","author":"Hamada","year":"2001","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.ajps.2022.07.004_bib0022","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0092-8674(00)81472-5","article-title":"Lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal","volume":"94","author":"Meno","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0023","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1074\/jbc.M108103200","article-title":"Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mrna expression and increased proteolytic activity in a fibrosarcoma model","volume":"277","author":"Mason","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2022.07.004_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2020.07.012","article-title":"Lefty2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-beta1\/Smad3 pathway","volume":"126","author":"Yang","year":"2020","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.ajps.2022.07.004_bib0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12265-020-10089-2","article-title":"Lefty1 ameliorates post-infarction fibrosis by suppressing p-Smad2 and p-ERK1\/2 signaling pathways","volume":"14","author":"Li","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"issue":"6","key":"10.1016\/j.ajps.2022.07.004_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060590","article-title":"Targeting activated hepatic stellate cells using collagen-binding chitosan nanoparticles for sirna delivery to fibrotic livers","volume":"12","author":"Azzam","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2022.07.004_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.587628","article-title":"Pathogenesis of viral hepatitis-induced chronic liver disease: role of extracellular vesicles","volume":"10","author":"Lim","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajps.2022.07.004_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.777462","article-title":"Human liver stem cell-derived extracellular vesicles target hepatic stellate cells and attenuate their pro-fibrotic phenotype","volume":"9","author":"Chiabotto","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.ajps.2022.07.004_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092180","article-title":"Intercellular communication between hepatic cells in liver diseases","volume":"20","author":"Sato","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ajps.2022.07.004_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050442","article-title":"Extracellular vesicle- and extracellular vesicle mimetics-based drug delivery systems: new perspectives, challenges, and clinical developments","volume":"12","author":"Gangadaran","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ajps.2022.07.004_bib0031","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"10.1016\/j.ajps.2022.07.004_bib0032","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/ijms17020172","article-title":"Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems","volume":"17","author":"Ohno","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2022.07.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121234","article-title":"An efficient photochemotherapy nanoplatform based on the endogenous biosynthesis of photosensitizer in macrophage-derived extracellular vesicles","volume":"279","author":"Li","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ajps.2022.07.004_bib0034","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv"},{"issue":"18","key":"10.1016\/j.ajps.2022.07.004_bib0035","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.7150\/thno.47865","article-title":"Extracellular vesicle-based nanotherapeutics: emerging frontiers in anti-inflammatory therapy","volume":"10","author":"Tang","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ajps.2022.07.004_bib0036","doi-asserted-by":"crossref","first-page":"e12047","DOI":"10.1002\/jev2.12047","article-title":"Single-vesicle imaging and co-localization analysis for tetraspanin profiling of individual extracellular vesicles","volume":"10","author":"Han","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ajps.2022.07.004_bib0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semcdb.2017.08.022","article-title":"Biogenesis and function of ESCRT-dependent extracellular vesicles","volume":"74","author":"Juan","year":"2018","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.ajps.2022.07.004_bib0038","article-title":"Routes and mechanisms of extracellular vesicle uptake","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"10.1016\/j.ajps.2022.07.004_bib0039","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1590\/1414-431X20132843","article-title":"Histone demethylase retinoblastoma binding protein 2 regulates the expression of alpha-smooth muscle actin and vimentin in cirrhotic livers","volume":"46","author":"Wang","year":"2013","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"10.1016\/j.ajps.2022.07.004_bib0040","doi-asserted-by":"crossref","first-page":"G628","DOI":"10.1152\/ajpgi.00137.2006","article-title":"Beneficial effect of glatiramer acetate (copaxone) on immune modulation of experimental hepatic fibrosis","volume":"292","author":"Horani","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087622000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087622000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:48:17Z","timestamp":1761724097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087622000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1818087622000769"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2022.07.004","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}